Literature DB >> 10466851

Dose-effect relationship between overdose mortality and prescribed methadone dosage in low-threshold maintenance programs.

E J van Ameijden1, M W Langendam, R A Coutinho.   

Abstract

The present study evaluates the effectiveness of low-threshold methadone maintenance in reducing overdose mortality. In a prospective cohort study conducted in Amsterdam, 498 Dutch injecting drug users (IDU) provided 1,969 person years of follow-up (1989-1995). Forty-four IDU died in this period, 15 due to illicit drug overdose. Compared to IDU not in maintenance, the adjusted relative risk for overdose mortality among those receiving 5-50 mg, 55-70 mg, and 75+ mg were 0.35, 0.13, and 0.11, respectively (p < .05). Also current injection use and HIV-seropositivity were independent predictors for overdose mortality. Whereas previous studies indicated effectiveness of methadone-assisted detoxification and high-dose maintenance programs in reducing mortality, the present study findings suggest that low-threshold maintenance programs also reduce overdose mortality, with higher dosages being most protective.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10466851     DOI: 10.1016/s0306-4603(98)00083-5

Source DB:  PubMed          Journal:  Addict Behav        ISSN: 0306-4603            Impact factor:   3.913


  14 in total

1.  Interpreting the relation between injection drug use and harm: a cautionary note.

Authors:  J F Anderson
Journal:  CMAJ       Date:  2000-06-13       Impact factor: 8.262

Review 2.  Methadone tolerance testing in drug misusers.

Authors:  Adam Bakker; Cindy Fazey
Journal:  BMJ       Date:  2006-11-18

3.  Density of low-barrier opioid agonist clinics and risk of non-fatal overdose during a community-wide overdose crisis: A spatial analysis.

Authors:  Ofer Amram; Eugenia Socías; Ekaterina Nosova; Thomas Kerr; Evan Wood; Kora DeBeck; Kanna Hayashi; Nadia Fairbairn; Julio Montaner; M J Milloy
Journal:  Spat Spatiotemporal Epidemiol       Date:  2019-07-04

4.  Do young heroin users in Madrid, Barcelona and Seville have sufficient knowledge of the risk factors for unintentional opioid overdose?

Authors:  Montserrat Neira-León; Gregorio Barrio; M Teresa Brugal; Luis de la Fuente; Rosario Ballesta; María J Bravo; Teresa C Silva; Alicia Rodríguez-Martos
Journal:  J Urban Health       Date:  2006-05       Impact factor: 3.671

5.  "I Was Not Sick and I Didn't Need to Recover": Methadone Maintenance Treatment (MMT) as a Refuge from Criminalization.

Authors:  David Frank
Journal:  Subst Use Misuse       Date:  2017-07-13       Impact factor: 2.164

Review 6.  HIV infection and risk of overdose: a systematic review and meta-analysis.

Authors:  Traci C Green; Samuel K McGowan; Michael A Yokell; Enrique R Pouget; Josiah D Rich
Journal:  AIDS       Date:  2012-02-20       Impact factor: 4.177

7.  No association between HIV status and risk of non-fatal overdose among people who inject drugs in Vancouver, Canada.

Authors:  Daniel J Escudero; Brandon D L Marshall; Thomas Kerr; Kanna Hayashi; Cindy Feng; Silvia A Guillemi; Robert S Hogg; Julio Montaner; Evan Wood; M-J Milloy
Journal:  Addict Behav       Date:  2016-04-01       Impact factor: 3.913

8.  Self-perceived health among Canadian opiate users: a comparison to the general population and to other chronic disease populations.

Authors:  Peggy E Millson; Laurel Challacombe; Paul J Villeneuve; Benedikt Fischer; Carol J Strike; Ted Myers; Ron Shore; Shaun Hopkins; Sara Raftis; Mary Pearson
Journal:  Can J Public Health       Date:  2004 Mar-Apr

9.  Overdose experiences among injection drug users in Bangkok, Thailand.

Authors:  M-J Milloy; Nadia Fairbairn; Kanna Hayashi; Paisan Suwannawong; Karyn Kaplan; Evan Wood; Thomas Kerr
Journal:  Harm Reduct J       Date:  2010-05-13

10.  The effects of maternally administered methadone, buprenorphine and naltrexone on offspring: review of human and animal data.

Authors:  W O Farid; S A Dunlop; R J Tait; G K Hulse
Journal:  Curr Neuropharmacol       Date:  2008-06       Impact factor: 7.363

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.